JB Chemicals & Pharmaceuticals zooms after reporting marginal rise in Q4 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
JB Chemicals & Pharmaceuticals is currently trading at Rs. 2050.00, up by 130.60 points or 6.80% from its previous closing of Rs. 1919.40 on the BSE.
The scrip opened at Rs. 1920.05 and has touched a high and low of Rs. 2079.00 and Rs. 1920.00 respectively. So far 15841 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2223.95 on 17-Apr-2023 and a 52 week low of Rs. 1339.05 on 16-Jun-2022.
Last one week high and low of the scrip stood at Rs. 2079.00 and Rs. 1829.30 respectively. The current market cap of the company is Rs. 15801.55 crore.
The promoters holding in the company stood at 53.93%, while Institutions and Non-Institutions held 27.71% and 18.36% respectively.
JB Chemicals & Pharmaceuticals has reported results for fourth quarter (Q4) and year ended March 31, 2023.
The company has reported 7.19% rise in net profit at Rs 88.67 crore for the quarter under review as compared to Rs 82.72 crore for the same quarter in the previous year. Total income of the company increased by 19.99% at Rs 702.44 crore for Q4FY23 as compared to Rs 585.43 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 3.13% rise in its net profit at Rs 87.63 crore for fourth quarter ended March 31, 2023 as compared to Rs 84.97 crore for the same quarter in the previous year. Total income of the company increased by 22.38% at Rs 766.90 crore for Q4FY23 as compared to Rs 626.67 crore for the corresponding quarter previous year.
For the year ended March 31, 2023, the company has reported 7.73% rise in its net profit at Rs 388.89 crore as compared to Rs 361.00 crore for the previous year. Total income of the company increased by 29.81% at Rs 2892.81 crore for year under review as compared to Rs 2228.49 crore for year ended March 31, 2022.
For the year ended March 31, 2023, on the consolidated basis, the company has reported 6.21% rise in its net profit at Rs 410.00 crore as compared to Rs 386.04 crore for the previous year. Total income of the company increased by 28.24% at Rs 3159.22 crore for year under review as compared to Rs 2463.47 crore for year ended March 31, 2022.
